Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Advancements in Blood Collection Tool
4.2.2 Increase in R&D Spending on Life Sciences
4.3 Market Restraints
4.3.1 Expensive Setups Hindering the Growth of the Market
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 Product
5.1.1 Sample Preparation Instrument
5.1.1.1 Extraction System
5.1.1.2 Workstation
5.1.1.3 Automated Evaporation System
5.1.1.4 Liquid Handling Instrument
5.1.1.5 Other Sample Preparation Instruments
5.1.2 Consumables
5.1.3 Sample Preparation Kit
5.1.3.1 Purification Kit
5.1.3.2 Isolation Kit
5.1.3.3 Extraction Kit
5.2 Application
5.2.1 Proteomics
5.2.2 Genomics
5.2.3 Epigenomics
5.2.4 Other Applications
5.3 End User
5.3.1 Pharmaceutical
5.3.2 Biotechnology
5.3.3 Molecular Diagnostics
5.3.4 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Bio-Rad Laboratories Inc.
6.1.3 Danaher Corporation
6.1.4 Illumina
6.1.5 Merck Millipore (Merck KGaA)
6.1.6 Perkinelmer
6.1.7 Qiagen
6.1.8 F. Hoffmann La Roche Ltd
6.1.9 Life Technologies (Thermo Fisher Scientific)


7 MARKET OPPORTUNITIES AND FUTURE TRENDS